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To create your abstract, type over the instructions in the template box below. Fonts or abstract dimensions should not be changed or altered. Increased levels of oxidative stress are closely linked with many neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis [1] [2] [3] . Whilst antioxidants have received attention as potential agents for managing such conditions, some clinical trials using recognised antioxidants such as vitamin E, vitamin C, pure scavenger molecules such as boldine, and NMDA receptor blockers, have resulted in conflicting results and conclusions 4, 5 . It is now believed that antioxidants not only reduce oxidative stress, but can also halt beneficial cellular processes. Therefore, it has been hypothesised that restoring the redox equilibrium by activation of intracellular signals involved in cell survival is more important 6 than solely restoring the redox equilibrium by direct scavenging of reactive oxygen species in the course of cellular oxidative stress. Hence, therapeutic strategies that aim to identify small molecules that confer neuroprotection against oxidative stress either by activating pro-survival regulatory pathways, or by increasing endogenous cellular antioxidant defences, may offer effective treatment for these neurodegenerative diseases 7, 8 . Identification of novel neuroprotective agents with favourable pharmacokinetic profiles and CNS distribution is also of pivotal importance for a successful clinical translation.
Thioflavones as novel neuroprotective agents
Flavones, a subclass of flavonoids, are polyphenolic phytochemicals that have been well recognised for their diverse pharmacological activities including neuroprotective 9, 10 activities.
In particular, several epidemiological in vitro and in vivo studies have highlighted the potential of flavonoids as neuroprotective agents. For example, natural flavonoids such as fisetin 8 , luteolin, quercetin, myricetin and hesperetin 4, 11, 12 have been reported to protect neurons against oxidative damage. Further, several synthetic flavones 13, 14 and thioflavones 15 have been reported to limit neurodegeneration associated with a variety of neurological disorders, namely Alzheimer's disease 16 (AD) and Parkinson's disease 17 (PD). Interestingly, flavonoids have been reported to increase cell survival in an oxidative stress model where scavenging antioxidants (vitamin E, boldine) failed to protect cells from the oxidative insult 4 . Also, growing bodies of evidence have attributed the neuroprotective abilities of flavonoids to their signalling regulation abilities [18] [19] [20] [21] . Further, studies focusing on the blood-brain barrier (BBB) permeability of flavonoids have highlighted that the lipophilic flavonoids possess greater BBB permeability than the polar flavonoids 22, 23 ; the permeability potency of the compounds also correlated with their lipophilicity (log P) [24] [25] [26] . With our interest in developing novel flavone derivatives as therapeutic agents, we had previously synthesised and characterised a library of 76 hydroxy flavones, methoxy flavones and their 4-thio derivatives 27 ( Figure-1 ). Intrigued by the neuroprotective potentials of flavones and by the higher lipophilicity of 4-thioflavones and methoxy flavones than their corresponding hydroxy flavones, in this study, an assessment of the neuroprotective abilities of the library of 76 flavones presented herein was carried out. Also, due to the absence of a systematic investigation of the effect of substitution of the 4-carbonyl (4-C=O) group by a 4-thiocarbonyl (4-C=S) group on the neuroprotective activities of flavones, we aimed to explore the structure-activity relationships (SARs) of the library of 76 flavones presented herein Figure 1 . Structures of flavones investigated in this study.
Materials and methods
Please see supplementary information. Figure- (Figure-1) . The purities of all compounds were established prior to evaluation, by reverse phase HPLC, and were found to be >95%.
Results and discussion

Library design As illustrated in
3.2
Neuroprotective evaluation All compounds were evaluated for their ability to protect neurons from H2O2-induced oxidative stress in an in vitro model using the SH-SY5Y human neuroblastoma cell line 28, 29 . An appropriate concentration of H2O2 for inducing oxidative stress in SH-SY5Y cells was determined by exposing the SH-SY5Y cells to various concentrations of H2O2 (5-500 µM) for 18 h. From the cell viability assessment, using the MTT assay, it was found that H2O2 at 130 µM (IC50 value) induced a 50% reduction in the SH-SY5Y cell viability (Supplementary info, Figure-S1 ). Hence, this concentration (130 µM) was used for further experiments to induce oxidative stress in SH-SY5Y cells. Next, the SH-SY5Y cells were treated with each of the compounds at the physiologically relevant concentration of 3 µM concentration 30 for 24 h prior to exposure to H2O2 (18 h). The cell viability was then determined by the MTT assay ( Figure- hydroxyl (m-hydroxy) groups) were found to be inactive (cell viability < 50%) whereas 1b, 4b and 5b with catecholic hydroxyl groups confer neuroprotection by restoring the cell viability > 80%. This suggests that the catecholic hydroxyl substitution is indispensable for neuroprotective activity.
ii) The B-ring phenyl group was vital for neuroprotective activity of catecholic flavones; replacing the B-ring phenyl group with its bioisosteres [series-2 (6b, 8b, 10b, 6d, 8d and 10d); cell viability < 60%] was detrimental for neuroprotective activity but incorporation of electron withdrawing groups on the B-ring phenyl group [series-3 (12b, 14b, 16b, 12d, 14d and 18d); cell viability > 85%] was beneficial. iii)
Methoxy flavones were less neuroprotective than their analogous hydroxyl flavones. iv)
For the synthetic flavones in series 2 and 3, the 4-thioflavones (C=S) [12f (cell viability = 97.4 ± 4.3%), 14f (cell viability = 106.7 ± 1.2%), 16f (cell viability = 97.8 ± 2.6%) and 18f (cell viability = 105.8 ± 3.7%)] were significantly more neuroprotective than the flavones (C=O) [12d (cell viability = 88.8 ± 2.5%), 14d (cell viability = 93.4 ± 1.4%), 16d (cell viability = 84.0 ± 3.6%), and 18d (cell viability = 84.6 ± 1.6%)]. However, the opposite trend was evident for the natural flavones in series 1 [1d (cell viability = 96.2 ± 1.3%) vs 1f (cell viability = 72.4 ± 1.2%); 4d (cell viability = 98.3 ± 2.1%) vs 4f (cell viability = 67.4 ± 1.3%)]. Compounds 1b, 4d, 12b, 12d, 14b, 14d, 16b, 16d, 18b and 18d that exhibited the highest neuroprotective effects at the single dose of 3 µM were further evaluated at lower concentrations to determine their ability to exert neuronal protection against H2O2-induced oxidative stress. Whilst no significant protective effects were observed at lower concentrations for 1b, 4b, 12b, 12d, 14b, 16b , compounds 14d and 18d were found to be effective even at 0.3 µM concentration (cell viability >70%) (Figure-3) . Importantly, compounds 1b, 4d, 12b, 12d, 14d, 16b and 18d were found to be nontoxic to SH-SY5Y cells at 3 µM and 10 µM doses for 24 h (as evidenced using the MTT assay). However, compound 16d caused 52% reduction in the cell viability at 10 µM, p < 0.001 (Figure-4) . of compounds 1b, 4d, 12b, 12d, 14b, 14d,  16b, 16d, 18b and 18d evaluated at 3 and 10 µM concentrations against SH-SY5Y cells. Cells without treatment serve as control. Data are expressed as the mean ± standard error of the mean (SEM) (n = 3). Statistical significance was estimated with respect to the control by one-way ANOVA, followed by Bonferroni's post hoc test (***p < 0.001).
3.3
Molecular mechanism of neuroprotection Flavones can act either as a free radical scavenger (antioxidant) or can trigger intracellular pathways for cell survival. Therefore, to gain insight into the mechanism of neuroprotection, their antioxidant potentials and impact on certain intracellular signalling targets were explored.
3.3.1
Antioxidant activity Flavones are very well known for their antioxidant activities 31, 32 , therefore the antioxidant properties of flavones 1b (7,8-dihydroxy flavone), 4b (luteolin, a well-known natural flavone) and compound-14b with a 4-C=O moiety, as well as the most neuroprotective 4-thioflavones (with 4-C=S) 14d, 16d and 18d were studied. For this, the flavones were evaluated at their neuroprotective concentration of 3 M both for their ability to directly interact with free radicals (primary antioxidant activity) using a DPPH free radical scavenging assay and for their ability to bind to ferrous (Fe 2+ ) ion that catalyses oxidation (secondary antioxidant activity), using a metal chelating assay (Table-1). As shown in Table 1 , all the aforementioned flavones showed very low scavenging activity (only up to 1.9% inhibition of DPPH radical) at 3 M. Also, based on previous reports on DPPH scavenging data for the well-known flavones (1b and 4d, Series-1), no correlation was found between the order of their neuroprotective abilities [1b (Cell viability-97%) > 4d (Cell viability-73%, p < 0.05)] and the order of their scavenging activity [DPPH radical scavenging activity-IC50-4d (11.04 ± 0.38 µM) > 1b (15.50 ± 0.12 µM)] 33 . Since, in general, compounds with catechol groups are defined as effective metal chelators [34] [35] [36] , the ironchelating ability of flavones 1b, 4d, 14b, 14d, 16d and 18d at 3 µM was further studied. Interestingly, a low degree of Fe 2+ chelation (only up to 5%) was exhibited by these flavones at 3 M concentration (Table 1) . Taken together, there was no observed correlation between the neuroprotective profiles and the antioxidant activities of flavones at their tested concentration. Therefore, it is possible that the flavones directly interact with cellular events leading to cell death after oxidative stress. Hence, the intracellular signalling pathways triggered by flavones in oxidative-stress induced SH-SY5Y cells were probed. 
3.3.2
Intracellular signalling Accumulative evidence has shown that flavonoids display signalling properties during neuroprotection 12, 21, [37] [38] [39] [40] . Hence, the potential intracellular signalling involved in the neuroprotective function of flavones were probed. For this, the signal mediated in SH-SY5Y cells by the well-known compounds 1b, 4b (luteolin) and compound-14b with a 4-C=O moiety, as well as the neuroprotective 4-thioflavones (with 4-C=S) 14d, 16d and 18d were studied. Pooled samples from three independent treatments of SH-SY5Y cells with and without H2O2 (130 µM), and with these compounds at 3 µM concentration for 24 h followed by the exposure to H2O2 (1 h) 38 , were analysed using the PathScan ® Intracellular Signalling Array Kit (Figure-5 ). These compounds were found to modulate the signalling molecules that are associated with cellular survival and apoptosis such as ERK1/2, mTOR, AMPKα and Akt targets such as Bad and PRAS40. Treatment of SH-SY5Y cells with H2O2 (130 µM) resulted in a marked reduction in phosphorylation of ERK1/2, mTOR, Bad and PRAS40. Pre-treatment with 7,8-dihydroxy flavones (containing 4-C=O) showed that compounds 1b and 4b were able to confer neuroprotection by the inhibition of apoptosis through restoration of Bad (a pro-apoptotic protein) phosphorylation (by inactivating its apoptotic activity), whereas, compound 14b was shown to elicit its activity through restoration of mTOR phosphorylation, which restores protein synthesis. In the case of 4-thioflavones, compound 14d significantly restored phosphorylation of ERK1/2, mTOR, Bad and PRAS40 up to the same levels or higher than that observed in the control, along with activation of AMPKα. Also, compound 18d was found to restore phosphorylation of ERK1/2 and mTOR, along with activation of AMPKα, however, compound 16d showed restoration of Bad phosphorylation only. These results support the in vitro observations and suggest that the neuroprotective effects of flavones are mediated via ERK1/2 and PI3K/Akt/mTOR pathways and that these flavones differentially activate the pro-survival protein kinases based on their chemical structure. Also, a comparison of intracellular signalling of the 4-thioflavone 14d with its corresponding flavone 14b highlights the beneficial influence of 4-C=S substitution on the neuroprotective activity. Thus, the enhanced neuroprotective effects of compounds 14d and 18d can be attributed to their potential to modulate multiple signalling targets. As several studies have highlighted compound-1b as a promising small molecular BDNF mimetic, with selective TrkB (Tropomyosin-related kinase B) receptor agonist activity [41] [42] [43] [44] [45] [46] [47] , it may be pertinent to explore the roles of compounds 14d and 18d in the modulation of the TrkB receptor in the future. without compounds 1b, 4b, 14b, 14d, 16d and 18d at 3 µM for 24 h before exposure to H2O2 (130 µM). Data are expressed as the mean ± standard error of the mean (SEM) (n = 4). Statistical significance was estimated with respect to the control (#) and with respect to H2O2 (*) by one-way ANOVA, followed by Bonferroni's post hoc test (ns-not significant, *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.001). (C) Molecular mechanism of action of 1b, 4b, 14b, 14d, 16d and 18d in SH-SY5Y cell line.
3.3.3
In silico prediction of BBB permeability For the flavones to be able to exert their neuroprotective effect clinically, permeation across the BBB is required. Therefore, BBB permeability scores were calculated for each flavone. These BBB permeability scores were then plotted against the neuroprotective ability to identify the most promising candidates (i.e. compounds with both high predicted permeation across the BBB and high neuroprotective activity, Figure-6 ). This showed that synthetic thioflavone compounds 14d and 18d possess both high neuroprotective ability (cell viability > 95%, neuroprotective even at 0.3 µM concentration) and high BBB permeability (BBB score > 0.02). In contrast, the natural/well-known flavones such as 7,8-dihydroxy flavone (1b), luteolin (4b) and quercetin (5b) were found to be neuroprotective but their poor BBB permeability scores might undermine the likelihood of achieving sufficiently high concentrations in the central nervous system. Therefore, the synthetic thioflavones 14d and 18d can be considered as lead candidates for further design and development of neuroprotective agents. Figure 6 . Graph represents BBB permeability of compounds (predicted BBB score) versus neuroprotective activity (cell viability) determined at 3 µM using the SH-SY5Y neuroblastoma cell line. The dashed line at x = 0.02 represents the threshold BBB-/BBB+ score and the dashed line at y = 50 represents 50% cell viability in SH-SY5Y cells exposed to H2O2.
Neuroprotective natural flavone/well-known flavones are highlighted in blue and the thioflavones that have been identified to be neuroprotective are highlighted in red. Lower left quadrant represents low neuroprotective activity and no BBB permeability, lower right quadrant represents low neuroprotective activity and high BBB permeability, upper left quadrant represents high neuroprotective activity and no BBB permeability and upper right quadrant represents high neuroprotective activity and high BBB permeability.
Conclusion
In summary, evaluation of the neuroprotective properties of structurally related methoxy flavones, hydroxy flavones and their 4-thio analogues has provided significant insights into the SARs of flavones, as summarised in Figure 7 . Overall, 7,8-dihydroxy 4-thioflavones such as compounds 14d and 18d were found to exhibit potent neuroprotective effects against H2O2-induced oxidative stress with their activity being restored even at 0.3 µM concentration. For 14d and 18d, high BBB permeability is also predicted.
Investigations of the molecular mechanism of action of 14d and 18d indicated that these compounds preferably mediate their neuroprotective effects through suppression of apoptosis by activating the anti-apoptotic proteins, and inactivating the pro-apoptotic proteins of the ERK1/2 and PI3K/Akt/mTOR pathways that are deregulated in AD 48 and PD 49 . As such, small molecules have been identified that confer neuroprotection against oxidative stress by activating prosurvival regulatory pathways. Therefore, the synthetic flavones 14d and 18d can be considered as promising candidates for further optimisation and development as neuroprotective agents. In this regard, future studies that will decipher the pharmacokinetic and pharmacodynamic properties of these synthetic compounds will further guide the optimisation of these candidates for neuroprotective applications.
